Cypherpunk Technologies, Inc. (CYPH)
2.55
+0.19
(+8.05%)
USD |
NASDAQ |
Nov 03, 14:04
Cypherpunk Technologies Total Liabilities (Quarterly) : 3.65M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.65M |
| March 31, 2026 | 3.003M |
| December 31, 2025 | 18.14M |
| September 30, 2025 | 8.704M |
| June 30, 2025 | 14.32M |
| March 31, 2025 | 14.04M |
| December 31, 2024 | 14.08M |
| September 30, 2024 | 16.09M |
| June 30, 2024 | 15.64M |
| March 31, 2024 | 10.59M |
| December 31, 2023 | 12.68M |
| September 30, 2023 | 11.04M |
| June 30, 2023 | 11.80M |
| March 31, 2023 | 10.50M |
| December 31, 2022 | 11.49M |
| September 30, 2022 | 12.09M |
| June 30, 2022 | 10.88M |
| March 31, 2022 | 7.344M |
| December 31, 2021 | 10.02M |
| Date | Value |
|---|---|
| September 30, 2021 | 11.26M |
| June 30, 2021 | 8.056M |
| March 31, 2021 | 7.428M |
| December 31, 2020 | 7.72M |
| September 30, 2020 | 7.406M |
| June 30, 2020 | 7.94M |
| March 31, 2020 | 10.78M |
| December 31, 2019 | 9.197M |
| September 30, 2019 | 8.579M |
| June 30, 2019 | 9.198M |
| March 31, 2019 | 9.019M |
| December 31, 2018 | 9.899M |
| September 30, 2018 | 20.50M |
| June 30, 2018 | 22.27M |
| March 31, 2018 | 22.56M |
| December 31, 2017 | 17.94M |
| September 30, 2017 | 5.994M |
| June 30, 2017 | 4.375M |
| March 31, 2017 | 4.612M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Indaptus Therapeutics, Inc. | 0.6154M |
| Cue Biopharma, Inc. | 28.40M |
| Yarrow Bioscience, Inc. | 1.542M |
| Faeth Therapeutics, Inc. | 9.581M |
| Pyxis Oncology, Inc. | 43.48M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 142.97M |
| Shareholders Equity (Quarterly) | 139.32M |
| Debt to Equity Ratio | 0.0003 |
| Current Ratio | 79.19 |
| Net Debt Paydown Yield | 0.15% |